x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Justice For Terror Victim Families | Kathua Administration welcomes first Batch of Amarnath Yatris at Lakhanpur | Yatra of resilience: LG to flag off first batch today after Pahalgam carnage, Op Sindoor | LG visits Yatri Niwas at Bhagwati Nagar, reviews arrangements | LG reviews final preparations | LG chairs high-level meeting, discusses issues of terror victim families | LG flags off fleet of ambulances in Ramban, Anantnag districts | 5 real brothers from Budgam among fraudulently selected candidates | Hope beneath the surface: Govt plans underground hospital in Poonch | ACB catches DDC member red handed | Crime Branch books J&K Bank officers, others for frauds | Back Issues  
 
news details
Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study
1/7/2023 11:00:05 PM
agencies
NEW DELHI, Jan 7: Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients than those who took the indigenously made Covaxin, according to a multi-centre study.
The yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found that when compared to pre-vaccination baseline, both vaccines elicited statistically significant antibody levels in both seronegative individuals and seropositive or those who had recovered from Covid-19 infection.
Between June 2021 and January 2022, the researchers enrolled 691 participants in the 18-45 age group across four sites in urban and rural Bengaluru and Pune
Participants received either two doses of Covaxin at 28 days apart or two doses of Covishield at three months apart. The Omicron wave in early 2022 overlapped with the second dose of vaccine in two sites and with both doses in one site.
Participants were sampled at six timepoints for antibody analyses and at four timepoints for cellular analyses. When compared to pre-vaccination baseline, both vaccines elicited statistically significant antibody levels in both seronegative and seropositive individuals, the researchers found. Covishield elicited immune responses of higher magnitude and breadth than Covaxin in both seronegative individuals and seropositive individuals, across cohorts representing the pre-vaccination immune history of the majority of the vaccinated Indian population.
Immunologist Vineeta Bal noted that in young adult population there is a difference in the response to Covid vaccines, if individuals are already infected with SARS-CoV-2 and recovered (seropositives) versus not infected. "In seronegatives, two doses of Covishield lead to higher magnitude of antibody levels in higher proportion of vaccine recipients as compared to Covaxin recipients," Bal, from Indian Institute of Science Education and Research (IISER), Pune and one of the study authors, told PTI.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU